|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
05.11.25 - 12:30
|
Elanco Animal Health Reports Third Quarter 2025 Results (PR Newswire)
|
|
|
Raising Full Year Outlook and Innovation Target, Improving Year-End Net Leverage Ratio Target Third Quarter 2025 Financial Results: Revenue of $1,137 million, an increase of 10% year-over-year; 9% organic constant currency growth Reported Net Loss of $34 million, Adjusted Net Income of......
|
|
|
|
|
|
|
|
|
|
|
16.10.25 - 22:33
|
Elanco to Host Investor Day on December 9 (PR Newswire)
|
|
|
INDIANAPOLIS, Oct. 16, 2025 /PRNewswire/ -- Elanco Animal Health, Inc. (NYSE: ELAN) will host an Investor Day on Tuesday, December 9, 2025, from approximately 9 a.m. to 12 p.m. Eastern Time in New York City. The event will feature presentations from Elanco's senior leadership team on the......
|
|
|
|
|
|
|
07.10.25 - 22:18
|
Acadia Healthcare Appoints Todd Young as Chief Financial Officer (Business Wire)
|
|
|
Young Brings 25 Years of Financial and Healthcare Industry ExperienceFRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (“Acadia” or the “Company”) today announced the appointment of Todd Young as Chief Financial Officer, effective October 27, 2025. Tim Sides, who has been serving as the Company's interim CFO since August 2025, will resume his role as Senior Vice President, Operations Finance.
Young brings to Acadia nearly a decade of executive-level finance experience at publicly traded healthcare companies. He most recently served as CFO at Elanco Animal Health (“Elanco”) where he joined in 2018 as Elanco was separating from Eli Lilly and Company. Young developed a robust finance organization and helped shape the company's strategic direction since its earliest days as an independent company. Prior to Elanco, Young served as the CFO of ACADIA Pharmaceuticals, where he revamped the company's financial processes and commercial pricing strategy for its flagship ...
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
